CURIS, INC. Common Stock ($0.01 par value per share) Sales AgreementSales Agreement • March 16th, 2021 • Curis Inc • Biological products, (no disgnostic substances) • New York
Curis, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (“Cantor”) and JonesTrading Institutional Services LLC (“JonesTrading”; each of Cantor and JonesTrading individually an “Agent” and collectively, the “Agents”), as follows:
